By Sabela Ojea
Shares of DaVita dropped after the company's guidance for the year fell short of Wall Street expectations.
The stock was down 7% to $164.75 in postmarket trading. Through Thursday's close, shares are up 18% year to date, and have surged 48% over the past 12 months.
The medical care services provider on Thursday said it expects adjusted earnings of $10.20 to $11.30 for 2025. Wall Street analysts expect full-year adjusted earnings of $11.38.
The company's outlook followed an increase in profit and revenue for the fourth quarter.
"Despite a year with unique hurdles, we finished strong in 2024," Chief Executive Javier Rodriquez said.
DaVita posted a net profit of $259.3 million, or $3.09 a share, compared with $150.7 million, or $1.62 a share, for the same period a year earlier.
Stripping out one-time items, the company's earnings per share came in at $2.24. Analysts polled by FactSet had forecast adjusted earnings of $2.13.
Quarterly revenue rose to $3.29 billion from $3.15 billion a year earlier, missing the $3.26 billion expected by Wall Street.
Write to Sabela Ojea at sabela.ojea@wsj.com
(END) Dow Jones Newswires
February 13, 2025 18:54 ET (23:54 GMT)
Copyright (c) 2025 Dow Jones & Company, Inc.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.